Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20562098 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Other: Intra-tumoral T4 immunotherapy

Indicates status has not been verified in more than two years